tbuckley/cabot-search huggingface dataset:
RESPIRATION VALVES.
Authors: C. C. GUTHRIE
Journal: JAMA (1907)

The valves shown in the accompanying drawing were designed primarily for use in preventing the waste of volatile anesthetics that commonly occurs in mammalian experiments when a Wollf's bottle is used in connection with a trachea tube and for simplifying the measurement of expired air in such experiments. Construction of plated brass with valve discs of aluminum, or of aluminum throughout, is satisfactory. An average of results from a test made on an 8 Kg. dog during a period of four hours is given below. The valves were not observed to stick or miss catching throughout the experiment. 1. Animal with tube in trachea breathing through a Wollf's bottle arrangement. Valves connected on the far side of the bottle in order to measure the volume of expired air. Volume of air measured by conveying it through a tube from the side branch to a spirometer. 2. Same arrangement as in
Development of the artificial heart and lung extracorporeal blood circuit
Authors: J. H. Gibbon
Journal: JAMA (1968)

Many well-documented accounts of the development of the artificial heart and lung extracorporeal blood circuit have been published. There is no merit in duplicating these scholarly histories. However, a personal narration of the origin and development of the artificial heart and lung extracorporeal blood circuit, hereinafter referred to more briefly, but less elegantly, as the "heart-lung machine" may prove of interest. The idea of constructing an artificial heart-lung machine occurred to me in 1931, because of circumstances surrounding the death of a patient from a massive pulmonary embolism. I was then a research fellow in surgery at Harvard, working under the direction of Edward D. Churchill, MD, at the Massachusetts General Hospital. At 3 P.M. one day early in 1931 a patient, who had had her gallbladder removed 15 days before, had a massive pulmonary embolism heralded by a severe pain in the chest and accompanied by a fall in
Incorrect Language in Figure and Text
Authors: Ellis Voerman, Vincent Jaddoe, Romy Gaillard
Journal: JAMA (2019)

US Preventive Services Task Force; Douglas K. Owens, MD, MS; Karina W. Davidson, PhD, MASc; Alex H. Krist, MD, MPH; Michael J. Barry, MD; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Alex R. Kemper, MD, MPH, MS; Martha Kubik, PhD, RN; C. Seth Landefeld, MD; Carol M. Mangione, MD, MSPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD
THE VENEREAL DISEASE PROBLEM IN WAR
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)*1
Authors: I WANLESS
Journal: Hepatology (1995)

The pathogenesis of congestive cirrhosis is generally thought to be a reaction of the hepatic stroma to hypoxia, pressure, or necrosis. This does not explain the poor correlation between symptoms and severity of fibrosis and the irregular distribution of fibrosis within the liver. We have observed healed hepatic vein (HV) thrombosis in patients with congestive heart failure (CHF). The purposes of this study were to document hepatic vascular lesions in autopsy livers of patients with chronic CHF, to determine the role of these lesions in the pathogenesis of congestive cirrhosis, and to refine the definition of congestive cirrhosis. Twenty-five livers were studied, 13 with multiple large blocks 4 × 5 cm. Sections were graded for parenchymal fibrous septa, sinusoidal fibrosis, and intimal fibrosis of portal veins (PVs) and HVs. Fibrous septa were found in livers of 7 of 13 patients with CHF and in none of 12 controls without CHF (P = .007). Parenchymal fibrosis was highly variable in distribution, often with severe septation in some areas and nearly normal morphology in others. Intimal fibrosis and obstruction of small- and mediumHVs were found only in livers of patients with CHF. The vascular lesions were confined to regions with fibrous septation and had morphology suggestive of organized thrombosis. Acute thrombi in sinusoids were noted in livers of 4 patients with CHF and in livers of 2 patients without CHF. These findings support the hypothesis that congestive cirrhosis is a response to intrahepatic thrombosis. The pattern of disease suggests that thrombus begins in sinusoids, occasionally propagates to HVs, and causes secondary local PV thrombosis, ischemia, parenchymal extinction, and fibrosis.
Military Medicine, Washington
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
INFANTILE PARALYSIS.
Authors: NORMAN TEAL
Journal: JAMA (1883)

[Read in the Section on Diseases of Children.] The subject of infantile paralysis is chosen in this instance for two main reasons: First, for what is not known of it; and second, for what ought to be, and possibly in time may be, learned of a malady of so frequent occurrence and so dire in consequences. The gospel preacher does best when discoursing from a substantial text, and so it is, I fancy, in regard to other speculative as well as practical subjects. Accordingly, for the better discussion of the subject in question, I will introduce a case in point, which will be recognized as a fair type of essential paralysis: A seventeen-month-old female child of previous good health and of good development was recently brought to me by the mother and the attending physician, presenting the following special symptoms: Complete<i>paraplegia</i>, considerable<i>dyspnæa</i>, slight<i>paresis</i>, involving the muscles of
AN INTERESTING CASE OF ASTHMA.
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Virologic Outcomes of Complex Drug Regimens for Human Immunodeficiency Virus
Authors: A. Carr
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
American College of Physicians Guidelines on Cholesterol Screening
Authors: Scott M. Grundy
Journal: Annals of Internal Medicine (1996)

Letters15 December 1996American College of Physicians Guidelines on Cholesterol ScreeningScott M. Grundy, MD, PhD and Thomas A. Pearson, MD, PhDScott M. Grundy, MD, PhDTask Force on Risk Reduction, American Heart Association, Dallas, TX 75231.Search for more papers by this author and Thomas A. Pearson, MD, PhDTask Force on Risk Reduction, American Heart Association, Dallas, TX 75231.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-125-12-199612150-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:In the 1 March 1996 issue, the American College of Physicians [1] recommends 1) limiting screening for lipid abnormalities to men aged 35 to 65 years and women aged 45 to 65 years and 2) using only the measurement of total serum cholesterol levels. The Task Force on Risk Reduction of the American Heart Association has carefully examined these new guidelines. In our view, the rationale for changing the guidelines is not justified, as we explain more thoroughly in a recent article in Circulation [2].We suggest that physicians consider several issues before adopting these new guidelines ...References1. American College of Physicians. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 1996; 124:515-7. Google Scholar2. Cholesterol screening in asymptomatic adults. No cause to change. Task Force on Risk Reduction, American Heart Association. Circulation. 1996; 93:1067-8. Google Scholar3. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Scandinavian Simvastatin Study Group. Lancet. 1994; 334:1383-9. Google Scholar4. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995; 333:1301-7. Google Scholar Author, Article, and Disclosure InformationAffiliations: Task Force on Risk Reduction, American Heart Association, Dallas, TX 75231. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 December 1996Volume 125, Issue 12Page: 1008KeywordsBloodCholesterolCoronary heart diseaseHypercholesterolemiaMortalityNutritionQuality of lifeScreening guidelinesStrokeYoung adults Issue Published: 15 December 1996 CopyrightCopyright © 1996 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
VIENNA
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Kinekard
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction: Identification of Persons at High Risk for Type 2 Diabetes Mellitus
Journal: Annals of Internal Medicine (2002)

Corrections17 September 2002Correction: Identification of Persons at High Risk for Type 2 Diabetes MellitusFREESearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-6-200209170-00037 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In an article on the identification of persons at high risk for type 2 diabetes mellitus (1), the formula in the Appendix on page 581 contained an error. The formula should read p = 1/(1 + e−x) rather than p = 1/(1 − e−x).Reference1. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136:575-81. [PMID: 11955025] LinkGoogle Scholar Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoIdentification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? Michael P. Stern , Ken Williams , and Steven M. Haffner Metrics 17 September 2002Volume 137, Issue 6Page: 553KeywordsType 2 diabetes ePublished: 17 September 2002 Issue Published: 17 September 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Serious Pasteurella multocida infections from lion and tiger bites
Authors: D. R. Burdge
Journal: JAMA (1985)

DOG and domestic cat bites are major public health problems,<sup>1-3</sup>and guidelines for their management have been established as a result of careful microbiological<sup>4-6</sup>and clinical studies.<sup>7-10</sup><i>Pasteurella multocida</i>is an important human pathogen, and its association with wound infections from animal bites is well recognized.<sup>11</sup> Serious<i>P multocida</i>infection from the bites of "large cats," such as the lion, tiger, panther, and leopard, has rarely been reported. We have cared for two patients who developed serious<i>P multocida</i>infection after encounters with such "big cats." The first patient developed pyogenic arthritis of the shoulder after a lion bite, and the second developed purulent meningitis within hours of being bitten by an adult bengal tiger. In both cases, the organism was inoculated directly into the joint or subarachnoid space by the deeply penetrating canine teeth of the animals. <h3>Report of Cases</h3><h3>Case 1.—</h3> A young Masai
Determination of measles, mumps, and rubella immunization status using oral fluid samples
Authors: T. Thieme
Journal: JAMA (1994)

<h3>Objective.</h3> —To determine if oral fluid samples can be used to reliably assess protective blood levels of antibodies to measles, mumps, and rubella. <h3>Design.</h3> —A comparison of matched serum and oral fluid samples from asymptomatic subjects in enzyme-linked immunosorbent assays for measles, mumps, and rubella antibodies. A longitudinal study compared matched serum and oral fluid samples from 11 subjects after measles-mumps-rubella vaccination. <h3>Setting.</h3> —Five US clinical sites with samples tested at the reporting laboratory. <h3>Participants.</h3> —A total of 157 asymptomatic subjects including 55 subjects younger than 18 years. <h3>Main Outcome Measures and Results.</h3> —The presence of antibodies in oral fluid specimens correlated with that in serum with the following levels of sensitivity and specificity: measles, 97% and 100%, respectively; mumps, 94% and 94%, respectively; rubella, 98% and 98%, respectively. Longitudinal studies of subjects after vac cination showed similar seroconversion profiles in oral fluid and serum samples. <h3>Conclusion.</h3> —Protective blood levels of antibodies to measles, mumps, and rubella can be assessed by means of an oral fluid sample with good reliability. (<i>JAMA</i>. 1994;272:219-221)
"SYMMETRICAL CYANODERMA"
Authors: Fred Wise
Journal: JAMA (1925)

<h3>To the Editor:</h3> —In the Rio de Janeiro letter (The Journal, November 28) appears the abstract of a report by Dr. Moreira de Fonseca, dealing with a matter entitled symmetrical cyanoderma. The description of the eruption is meager, but, judging from the brief account, the lesions and their mode of involution are very strongly suggestive of an eruption due to either phenolphthalein or antipyrin, administered by mouth. It would be unwise to burden our overcrowded dermatologic nomenclature with the term "symmetrical cyanoderma," for it might be readily confused with such diseases as erythromelalgia, Raynaud's disease, pernio and erythredema.
Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence
Authors: L. A. Lipsitz
Journal: JAMA (1992)

The concept of "complexity," derived from the field of nonlinear dynamics, can be adapted to measure the output of physiologic processes that generate highly variable fluctuations resembling "chaos." We review data suggesting that physiologic aging is associated with a generalized loss of such complexity in the dynamics of healthy organ system function and hypothesize that such loss of complexity leads to an impaired ability to adapt to physiologic stress. This hypothesis is supported by observations showing an age-related loss of complex variability in multiple physiologic processes including cardiovascular control, pulsatile hormone release, and electroencephalographic potentials. If further research supports this hypothesis, measures of complexity based on chaos theory and the related geometric concept of fractals may provide new ways to monitor senescence and test the efficacy of specific interventions to modify the age-related decline in adaptive capacity. (<i>JAMA</i>. 1992;267:1806-1809)
A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy
Authors: Mark R. Gilbert, Henry S. Friedman, John F. Kuttesch, Michael D. Prados, Jeffrey J. Olson, Gregory H. Reaman, Sara L. Zaknoen
Journal: Neuro-Oncology (2002)

Neuro-OncologyTemozolomide is a novel second-generation oral alkylating agent with demonstrated ef cacy and safety in patients with recurrent glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA).A multicenter phase II trial was conducted to determine the ef cacy and safety of temozolomide before radiotherapy in patients with newly diagnosed GBM and AA.Fifty-seven patients (51 adult, 6 pediatric) with newly diagnosed supratentorial GBM or AA were treated with temozolomide (200 mg/m 2 per day for 5 consecutive days every 28 days) for a maximum of 4 cycles.All patients were then treated with external beam radiotherapy.Twenty-two patients (39%) achieved objective response, including 6 (11%) with complete response (CR) and 16 (28%) with partial response (PR).Additionally, 18 (32%) patients had stable disease (SD).Of 21 patients (18 adult, 3 pediatric) with AA, 2 (10%) achieved CR, 5 (24%) achieved PR, and 8 (38%) had SD.Among